# OnCo record nabilone (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/nabilone/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "nabilone" ;
  schema:name "Nabilone"@en ;
  schema:description "Nabilone is a synthetic cannabinoid capsule approved in 1985 for chemotherapy-induced nausea and vomiting that standard drugs cannot control; like dronabinol it is a later-line option because of its effects on mood and balance."@en ;
  schema:url <https://onco.cc/drugs/nabilone/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Nabilone> ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018677>, <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=nabilone>, <https://en.wikipedia.org/wiki/Nabilone> ;
  onco:status "established" ;
  onco:tag "gap-fill", "chembl-universe" ;
  onco:modality "Oral small-molecule synthetic cannabinoid" ;
  schema:alternateName "Cesamet" ;
  onco:approval "US 1985: Nausea and vomiting from cancer chemotherapy in patients who have failed conventional antiemetics" ;
  onco:targets <https://onco.cc/targets/cnr1/> ;
  onco:drugs <https://onco.cc/drugs/dronabinol/> ;
  onco:companies <https://onco.cc/companies/eli-lilly/> ;
  onco:trials <https://onco.cc/trials/nct02802540/> .